Immune Cell-Poor Melanomas Benefit from PD-1 Blockade after Targeted Type I IFN Activation

Title
Immune Cell-Poor Melanomas Benefit from PD-1 Blockade after Targeted Type I IFN Activation
Authors
Keywords
-
Journal
Cancer Discovery
Volume 4, Issue 6, Pages 674-687
Publisher
American Association for Cancer Research (AACR)
Online
2014-03-04
DOI
10.1158/2159-8290.cd-13-0458

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search